Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer?

April 26, 2017age allocation comorbidity impact limited lung cancer Outcomes small-cell Stage treatment

0

Posted

Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer?

1 Answer

0

Posted

The effects of age and comorbidity on treatment and outcomes for patients with limited stage small-cell lung cancer (L-SCLC) are unclear. This study analyzes relapse and survival in a community-based population with L-SCLC according to age and comorbidity.